The fund has raised about $15m in seed round funding from internal sources and close associates and has closed its first investment, GlucoTec.

Venture capital firms Hatteras Venture Partners, which led the $2.6m B round in 2007, and Brook Private Equity Advisors also participated in the $15m C round for Clinipace Worldwide.

The three health insurance companies will combine to help Bloom create a nationwide defined contribution system for employers.

NuScriptRX has raised $8m of funding from a range of venture capital firms, several of which operate under the local TNInvestco program.

Alongside Amgen Ventures, which was founded in 2004, in Ardelyx's $30m B round were venture capital firms NEA and CMEA and individual investors.

Last month, DST Global, the fund run by Russian businessman Yuri Milner, invested $50m in ZocDoc.

WuXi set up its corporate venturing unit after the collapse of its $1.6bn merger with Charles River Laboratories in July last year.